2070009-25-3
Chemical Structure
Sofosbuvir-13C,d3
Synonym(s): PSI-7977-13C,d3;GS-7977-13C,d3
- CAS No.: 2070009-25-3
- Formula:C2113CH26D3FN3O9P
- Molecular Weight:533.46
IUPAC Name: isopropyl ((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-(methyl-13C-d3)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate
InChIKey: TTZHDVOVKQGIBA-VKRIPBSLSA-N
SMILES: O=C1N([C@H]2[C@]([C@H](O)[C@@H](CO[P@](OC3=CC=CC=C3)(N[C@@H](C)C(OC(C)C)=O)=O)O2)([13C]([2H])([2H])[2H])F)C=CC(N1)=O
Biological Activity: Sofosbuvir-13C,d3 is the deuterium labeled Sofosbuvir. Sofosbuvir (PSI-7977) is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sofosbuvir-13C,d3 | Sofosbuvir-13C,d3 is the deuterium labeled Sofosbuvir. Sofosbuvir (PSI-7977) is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sofosbuvir (Standard) | 99.99% | Sofosbuvir (Standard) is the analytical standard of Sofosbuvir. This product is intended for research and analytical applications. Sofosbuvir (GS-7977) is an HCV RNA replication inhibitor with an EC50 of 92 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sofosbuvir-d6 | 98.07% | Sofosbuvir-d6 is the deuterium labeled Sofosbuvir. Sofosbuvir (PSI-7977) is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sofosbuvir | 99.97% | Sofosbuvir (GS-7977) is an HCV RNA replication inhibitor with an EC50 of 92 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
